China Trading Desk Launches Comprehensive China Travel Dashboard Amid Rising Outbound Travel
25.7.2023 10:27:00 EEST | Business Wire | Press release
China Trading Desk, a premier provider of marketing and advertising solutions for the Chinese market, is proud to announce the release of our game-changing tool - the China Travel Dashboard. Built to provide unparalleled insights into the evolving attitudes, expectations, and behaviours of outbound travellers from China, this dashboard is born out of our deep understanding of the Chinese market, a sector that has witnessed a remarkable upward trajectory in recent years.
Our newly launched China Travel Dashboard is designed to act as a compass, helping our clients navigate the complexity of this dynamic market. The dashboard brings a treasure trove of critical information to your fingertips, transforming it into a must-have tool for formulating and executing digital marketing campaigns aimed at Chinese tourists.
Here's a quick overview of the unique modules the China Travel Dashboard encompasses:
- Travel Sentiment: This module features an exhaustive quarterly survey helmed by China Trading Desk, assessing the travel inclinations of potential Chinese outbound travellers, thereby providing a snapshot of emerging trends.
- Pre-Trip: Developed in partnership with VariFlight, this module delivers real-time travel data including daily airport traffic flow from all airports in China to a selected group of 25 countries around the world, providing a glimpse into preferred destinations.
- In-Trip: Partnering with UnionPay, this module offers an exclusive window into Chinese tourists' spending patterns and preferences while they're immersed in their travel experiences.
Subramania Bhatt, Founder & CEO of China Trading Desk, stated, "We are thrilled to bring this comprehensive tool to our esteemed clients. The China Travel Dashboard is a solid reflection of our relentless commitment to staying on the cutting edge of providing data that's most relevant for our advertisers and agencies. As the outbound travel market in China continues to expand, we are confident this tool will prove to be indispensable in aiding businesses and advertisers to effectively understand, reach, and engage with Chinese tourists."
The dashboard’s data allows businesses to formulate personalized marketing strategies, optimize ad scheduling, undertake destination marketing, predict upcoming trends, and facilitate product development. Notably, several renowned brands including a global luxury conglomerate and the world's largest hospitality chain, have beta-tested the Dashboard and acclaimed it as the most comprehensive tool to understand Chinese travel insights and behaviour.
For more information visit the China Travel Dashboard.
About China Trading Desk:
China Trading Desk is a marketing technology company enabling brands & agencies to help advertise in China & across the world. Our suite of products focuses on China advertising and Chinese travellers and enables advertisers to effectively reach out to their target audience. CTD works with some of the world’s most pioneering brands including Singapore Airlines, HSBC, LVMH Group, Qatar Airways, etc. We are headquartered in Singapore with offices in Hong Kong, Shanghai, Shenzhen, Guangzhou, and affiliates in Dubai, London and New York.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230724321638/en/
Contact information
China Trading Desk
Marketing Department
+6566992226
Hello@chinatradingdesk.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer13.7.2026 13:00:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross proceeds, before the deduction of private placement expenses, and up to an additional $255 million upon the full exercise of purchase warrants. The financing was led by Commodore Capital, with participation from RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals. The net proceeds of this financing are expected to support Agenus’ strategic prioritization of botensilimab and balstilimab (BOT+BAL) for the neoadjuvant treatment of microsatellite-stable (MSS) colon cancer, including advancement of ROBBIN1, the Company’s planned registrational Phase 3 neoadjuvant trial in microsatellite-stable (MSS) colon cancer. High-risk Stage II and Stage III MSS colon cancer affect an estimated 38,000 patients annually in the US and more than 200,000 patients worldwide,2 representing a
Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation13.7.2026 12:48:00 EEST | Press release
The Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, has officially closed submissions for its 2027 awards cycle, receiving an unprecedented 10,233 entries from 177 countries across its six categories of Health, Food, Energy, Water, Climate Action and Global High Schools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713519403/en/ Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation (Photo: AETOSWire) Now in its 18th year, the Prize continues to attract a diverse and growing pool of small and medium-sized enterprises, nonprofit organisations and high schools developing solutions that improve lives, particularly in vulnerable and underserved communities. This year’s submissions point to a growing emphasis on resilience, adaptability and systems-level impact. Across regions, applicants are addressing complex global challenges through practi
Ant Group Open-Sources SingGuard-NSFA to Establish New Security Paradigms for Autonomous AI Agents13.7.2026 12:01:00 EEST | Press release
Ant Group’s AI Security Lab today announced the open-source release of SingGuard-NSFA, a specialized security guardrail framework designed specifically for autonomous AI agents. The framework secures agentic AI systems against operational threats like prompt injection, addressing critical vulnerabilities as AI transitions from passive content generation to active, autonomous execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712722454/en/ As AI agents rapidly move from research labs to business scenarios, the security landscape has fundamentally shifted. The explosive global adoption of open-source agent frameworks like OpenClaw, celebrated for their "one-click deployment" and "full-stack autonomy", has simultaneously exposed significant operational risks, including permission escalation and prompt injection. Industry frameworks, including the OWASP (Open Web Application Security Project) Top 10 for Agentic Applica
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types13.7.2026 11:00:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, investigational monoclonal antibody for patients with von Willebrand disease (VWD). The data are being shared in an oral presentation today at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH 2026 Congress) in Paris. Latarcibart modulates Protein S to improve hemostasis, potentially enhancing the body’s ability to prevent or reduce the frequency of bleeding episodes. Latarcibart is in pivotal Phase 3 development for patients with VWD, the most common inherited bleeding disorder. If approved, latarcibart has the potential to be the first, once monthly subcutaneous prophylactic therapy for patients with VWD, offering an important alternative to the frequent intravenous infusions of replacement factor concentrates commonly used in the prophylactic setting today. Gi
Europe’s Demand for Tech Services Accelerates in Q2, As Spending on AI and Managed Services Rises: ISG Index™13.7.2026 11:00:00 EEST | Press release
Demand for technology services in Europe continued to accelerate in the second quarter, as the region increasingly turns to managed services to reduce costs and cloud services to meet AI objectives, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows second-quarter ACV for the combined market (both managed services and cloud-based as-a-service) soared 46 percent—its largest growth in eight years—to US $13.0 billion. The latest quarter adds to a string of three straight quarters in which growth has averaged 33 percent. “Europe has become the fastest-growing region for technology services, fueled not only by an increasing demand for AI, but for managed services, which acts as a cost-savings lever to help fund AI ambitions and continued digital
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom